Deficiency of Parkinson's disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation.
The Parkinson's disease (PD)-related protein F-box only protein 7 (Fbxo7) is the substrate-recognition component of the Skp1-Cullin-F-box protein E3 ubiquitin ligase complex. We have recently shown that PD-associated mutations in Fbxo7 disrupt mitochondrial autophagy (mitophagy), suggesting a role for Fbxo7 in modulating mitochondrial homeostasis. Here we report that Fbxo7 deficiency is associated with reduced cellular NAD+levels, which results in increased mitochondrial NADH redox index and impaired activity of complex I in the electron transport chain. Under these conditions of compromised respiration, mitochondrial membrane potential and ATP contents are reduced, and cytosolic reactive oxygen species (ROS) production is increased. ROS activates poly (ADP-ribose) polymerase (PARP) activity in Fbxo7-deficient cells. PARP inhibitor restores cellular NAD+content and redox index and ATP pool, suggesting that PARP overactivation is cause of decreased complex I-driven respiration. These findings bring new insight into the mechanism of Fbxo7 deficiency, emphasising the importance of mitochondrial dysfunction in PD.
Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK.
Marta
M
Delgado-Camprubi
Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK.
Noemi
N
Esteras
Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK.
Marc Pm
MP
Soutar
Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK.
Helene
H
Plun-Favreau
Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK.
Andrey Y
AY
Abramov
D000255:Adenosine Triphosphate / Q000378:metabolism; D002478:Cells, Cultured; D042967:Electron Transport Complex I / Q000037:antagonists & inhibitors / Q000378:metabolism; D044783:F-Box Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D019807:Iodoacetic Acid / Q000494:pharmacology; D007546:Isoquinolines / Q000494:pharmacology; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*; D063306:Mitophagy / Q000187:drug effects; D009243:NAD / Q000737:chemistry / Q000378:metabolism; D010101:Oxygen Consumption; D010300:Parkinson Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D010880:Piperidines / Q000494:pharmacology; D000067856:Poly(ADP-ribose) Polymerase Inhibitors / Q000494:pharmacology; D011065:Poly(ADP-ribose) Polymerases / Q000737:chemistry / Q000378:metabolism*; D020641:Polymorphism, Single Nucleotide; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D012966:Sodium Cyanide / Q000494:pharmacology
D044783:F-Box Proteins; C489149:FBXO7 protein, human; D007546:Isoquinolines; D010880:Piperidines; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D034741:RNA, Small Interfering; D017382:Reactive Oxygen Species; D009243:NAD; C108729:3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone; D000255:Adenosine Triphosphate; D011065:Poly(ADP-ribose) Polymerases; D042967:Electron Transport Complex I; D012966:Sodium Cyanide; D019807:Iodoacetic Acid
Nat Neurosci. 2013 Sep;16(9):1257-65
23933751
Cell Death Dis. 2012 Jun 28;3:e335
22739987
Cell. 1996 Jul 26;86(2):263-74
8706131
Nat Neurosci. 2013 Oct;16(10 ):1392-400
23974709
J Inherit Metab Dis. 2012 Mar;35(2):211-25
21874297
J Physiol. 2007 Dec 15;585(Pt 3):741-58
17947304
Parkinsons Dis. 2010 Dec 22;2011:951709
21234368
Antioxid Redox Signal. 2012 May 1;16(9):920-34
21554057
Science. 2004 Mar 26;303(5666):2011-5
14976264
PLoS One. 2013 Nov 21;8(11):e79757
24278171
Cell Metab. 2012 Sep 5;16(3):290-5
22921416
Neurosci Lett. 2008 Dec 5;447(1):17-9
18840506
Cell Death Differ. 2012 Feb;19(2):257-66
21701498
Biochem Biophys Res Commun. 2003 Sep 5;308(4):809-13
12927790
Pharmacol Rev. 2012 Jan;64(1):166-87
22106091
J Biol Chem. 2014 Sep 19;289(38):26213-25
25096575
Brain. 2011 Jun;134(Pt 6):1658-72
21616968
Stroke. 2008 Sep;39(9):2587-95
18617666
PLoS One. 2011;6(8):e23295
21858060
Mol Cells. 2013 Sep;36(3):258-66
23996529
Lancet Neurol. 2008 Jan;7(1):97-109
18093566
Biochem J. 2011 Apr 15;435(2):297-312
21726199
Curr Opin Pharmacol. 2008 Feb;8(1):96-103
18032109
Mech Ageing Dev. 2015 Mar;146-148:53-64
25881554
Cell. 1997 Oct 17;91(2):209-19
9346238
Brain. 1999 Feb;122 ( Pt 2):247-53
10071053
Neurochem Res. 2013 Jan;38(1):50-8
23011206
Brain Res. 2013 Oct 16;1535:14-23
23994215
Cell Mol Life Sci. 2005 Apr;62(7-8):721-30
15868397
Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10209-14
24987120
J Geriatr Psychiatry Neurol. 2010 Dec;23 (4):228-42
20938043
Science. 2002 Jul 12;297(5579):259-63
12114629
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3374-9
18296641
Mol Cell. 2009 Mar 13;33(5):627-38
19285945
Methods Mol Biol. 2015;1264:263-70
25631020
Cell Rep. 2014 Sep 25;8(6):1819-31
25220464
Mol Cell Biol. 2014 Aug;34(16):3024-40
24912681
Open Biol. 2013 Oct 09;3(10 ):130131
24107298
J Neurosci. 2010 Feb 24;30(8):2967-78
20181594
PLoS One. 2011;6(10):e25622
22043288
Endocr Rev. 2010 Apr;31(2):194-223
20007326
Neurochem Res. 2004 Mar;29(3):569-77
15038604
Biochim Biophys Acta. 2010 Mar;1800(3):297-304
19695307
Cardiovasc Res. 2004 Sep 1;63(4):682-8
15306224
Neuron. 2015 Jan 21;85(2):257-73
25611507
Biochim Biophys Acta. 2008 Jul-Aug;1777(7-8):953-64
18471431
Expert Opin Ther Targets. 2010 May;14(5):497-511
20334487
Cell. 2006 Dec 15;127(6):1109-22
17112576
Mol Cell Biol. 2008 Jan;28(2):814-24
17991898
Neurology. 2009 Jan 20;72(3):240-5
19038853
Free Radic Biol Med. 2002 Nov 15;33(10 ):1372-9
12419469
Brain Res. 2008 Jan 16;1189:215-8
18061150
Cell. 2007 Jul 27;130(2):309-21
17662945
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14447-52
18794531
Biochem J. 2009 Jan 1;417(1):1-13
19061483
Lancet. 1989 Jun 3;1(8649):1269
2566813
J Cell Mol Med. 2008 Aug;12(4):1220-8
18782186
Biochem Biophys Res Commun. 2007 Jun 8;357(3):596-602
17449015
FEBS J. 2013 Oct;280(20):5080-93
23937586